Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.9K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

701
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
701
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

986
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
986
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

256
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
256
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental factors that regulate host-helminth interactions.

Trends in parasitology·2026
Same author

Limb-Shaking Transient Ischemic Attacks in a Case of Brachiocephalic Artery Stenosis.

JACC. Case reports·2025
Same author

Notch-activated basophils support intestinal CD4<sup>+</sup> T cell fate and function during Trichuris muris infection.

Mucosal immunology·2025
Same author

Real-World Experience Using Proton Versus Photon Craniospinal Irradiation for Leptomeningeal Disease.

Practical radiation oncology·2025
Same author

Enteric tuft cell inflammasome activation drives NKp46+ILC3 IL22 via PGD2 and inhibits Salmonella.

The Journal of experimental medicine·2025
Same author

Recurrent adamantinomatous craniopharyngioma stabilized with tocilizumab and bevacizumab: illustrative case.

Journal of neurosurgery. Case lessons·2025

Related Experiment Video

Updated: Dec 18, 2025

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
10:30

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice

Published on: January 25, 2017

9.2K

Exercising Immunity: Interleukin-13 Flexes Muscle.

Lauren M Webb1, Elia D Tait Wojno1

  • 1Department of Immunology, University of Washington, Seattle, WA, USA.

Immunity
|June 20, 2020
PubMed
Summary

Endurance exercise induces muscle adaptations for better performance. A new study reveals that interleukin-13 (a type 2 cytokine) plays a key role in the metabolic reprogramming required for these endurance exercise adaptations.

Area of Science:

  • Exercise physiology
  • Immunology
  • Molecular biology

Background:

  • Endurance exercise necessitates significant physiological adaptations within skeletal muscle to enhance performance.
  • The molecular mechanisms underlying exercise-induced muscle adaptation are complex and involve metabolic reprogramming.
  • The role of specific cytokines in mediating these adaptations remains an active area of research.

Purpose of the Study:

  • To investigate the role of type 2 cytokines in skeletal muscle adaptation to endurance exercise.
  • To elucidate the involvement of interleukin-13 in exercise-induced metabolic reprogramming.
  • To understand how interleukin-13 contributes to enhanced endurance performance.

Main Methods:

  • Utilized mouse models to study the effects of endurance exercise.

More Related Videos

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.6K
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.7K

Related Experiment Videos

Last Updated: Dec 18, 2025

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
10:30

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice

Published on: January 25, 2017

9.2K
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.6K
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.7K
  • Investigated the expression and function of interleukin-13 in muscle tissue.
  • Employed molecular and biochemical techniques to analyze metabolic pathways.
  • Assessed physiological parameters related to exercise performance.

    • Main Results:

    • Knudsen et al. identified a crucial role for interleukin-13 (IL-13) in endurance exercise adaptation.
    • IL-13 was found to orchestrate metabolic reprogramming in muscle tissue.
    • The study demonstrated that IL-13 signaling is essential for optimizing muscle function during prolonged exercise.
    • Specific metabolic pathways regulated by IL-13 were identified.

    Conclusions:

    • Interleukin-13 is a key mediator of skeletal muscle adaptation to endurance exercise.
    • IL-13 drives metabolic reprogramming, enhancing the muscle's capacity for sustained energy production.
    • Targeting IL-13 signaling pathways may offer novel strategies for improving endurance performance.